Webe Honey – Lifestyle
Home
Sample Page
Author:
IN8bio, Inc
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
May 6, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 3, 2026
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results – Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
March 12, 2026